A study of sister chromatid exchange and somatic cell mutation in hospital workers exposed to ethylene oxide. by Tomkins, D J et al.
Environ 1mental Health Perspectives Supplements
Vol. 101 (Suppl. 3): 159-164 (1993)
A Study of Sister Chromatid Exchange and
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by Darrell J. Tomkins,12 Ted Haines,' Murray Lawrence,3
and Nadia Rosa1
To investigate the risks ofexposure to ethylene oxide (EO) at current permissible levels and at past higher
levels, an inception cohort of sterilizer operators and supervisors from the Central Processing Department
(CPD), respiratory therapists, and engineers exposed to EO were identified at the McMaster University
Medical Centre. Acomparison group from Nutrition Services (NUTR) were matched withthe CPD workers on
the basis ofsex, age, and smoking habit. The present report is based on genetic test results forthe 94 CPD and
matched NUTRworkers only. Statistical analysis basedon the mean SCE frequency in the top 5, top10, and all
cells (50 cells scored per individual) and high frequency cells (HFC) based on the 95th percentile for
nonsmoking control subjects showed a direct association with current smoking but not with EO exposure.
Similarly, statistical analysis ofthesomatic cell mutation (SCMT)variant frequencies did notdemonstrate an
association with EO exposure, nor with smoking. Regression analysis indicated that sex was the only other
covariate that significantly affected SCE. Age was weakly associated with SCMT. A statistically significant
interaction between occupational exposure andsmokinghabits wasobservedonlyforthe meanSCE frequency
of the top 5 and top 10 cells when the 11 current CPD/NUTR pairs were not included. Thus, this interaction
should be interpreted with caution.
Introduction
Ethylene oxide (EO) is used extensively in health care
institutions for sterilization of heat-sensitive materials
and is considered irreplaceable forthis purpose. Exposure
of hospital workers to EO can occur even in the usual
operation of properly maintained sterilizers. Malfunction
ofequipment orimproperprocedures haveresultedinhigh
levels of exposure.
EO is a suspected human carcinogen. EO is carcino-
genic in animals; in rats it causes dose-related increases in
mononuclear cell leukemias, peritoneal mesotheliomas,
and cerebral gliomas (1). Epidemiologic evidence supports
the possibility that EO causes cancer in man, increasing
the risk of leukemia and stomach cancer (2). Recent evi-
dence suggests that excess hematopoietic cancer, at least
in males, may be associated with a long duration of EO
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exposure and long latent periods (3). This association may
betheresult ofexposure to higherlevels ofEO in the past.
The genotoxic risks of exposure to EO in the range of
10-50 ppm are relatively well understood. However, it is
uncertain whether exposure at the levels nowprevalent in
Ontario hospitals (generally well under an 8-hr TWA of 1
ppm) poses these risks. In addition, thereis littleinforma-
tion concerning whether workers previously exposed to
higher levels and not currently exposed might have per-
sisting evidence oftoxicity.
A group of hospital workers brought their concerns
regarding the possible health effects of past and current
exposure to EO to the Occupational Health Program,
McMasterUniversity.Astudyofallemployees eversignif-
icantly exposed to EO at the McMaster University Medi-
cal Centre, Chedoke-McMaster Hospitals, was initiated to
investigate health effects of exposure to EO from com-
mencementofoperationin 1971tothepresent. Thepresent
report is restricted to the results of the genotoxicologic
aspects ofthe investigation.
Study Groups
An inception cohort of sterilizer operators and super-
visors from the Central Processing Department (CPD),
respiratorytherapists, and engineers exposed to EO were
identified at the McMaster University Medical Centre.TOMKINS ET AL.
There was an overall recruitment ofmore than 80% into
the study: 47 CPDworkers, 6 respiratorytherapists, and1
engineer. For the period from 1971 until 1981, there is no
record of exposure measurement. However, during the
same period, in some instances hospital exposures in
Ontario and the United States were estimated to have
exceeded an 8-hrTWAof10-50 ppm (4,5). In 1981, atable-
top sterilizer was discovered to have a leak; no record of
exposure measurement has been found, but this sterilizer
has been discarded. In 1982, levels exceeding 1000 ppm
were detected in front of an Amsco sterilizer from a
leaking door, and levels between 32 and 93 ppm were
recorded around edges of the closed door on two other
occasions. In the latter instances, faulty equipment was
repaired, and three additional aerators, another sterilizer,
and local exhaustventilation were installed. Bythe end of
1984, no EO was detected by the threshold limit value
(TLV) sniffing around operating machines. In 1985, levels
of100 ppm were measured immediately after sterilization
before aeration, and a level of2 ppm was noted above the
load during transfer to aerator. However, after aeration
there was no detectable EO. Since January 1986, personal
diffusion monitors with a detection limit of 0.1 ppm have
indicated moderate EO elevation on two occasions: on one
occasion aworker's monitorwas positive for EO exposure
after anepisode ofmanual transferofsterilized objects to
the aerator when a load tipped over. On the other, a
positivemonitorindicated aventilation malfunction,which
was rectified. An area alarm system for EO was subse-
quently installed, and no further episodes of elevated
exposures have been recorded.
Comparison subjects from Nutrition Services (NUTR)
were matched with EO workers on the basis of sex, age
(classified either as40andgreater, orlessthan40yearsof
age)and smokinghabit(classified ascurrentlysmokers or
nonsmokers). Both current and past CPD workers were
matched with current NUTR employees, as it was not
feasibletomatchpastworkers onthebasisoftheinterven-
ing work experience. The present report is based on the
genetic testresults fromthe 94 CPD and matched NUTR
workers; the other job categories had small numbers of
individuals (six exposed respiratory therapists and one
exposedengineer). Table 1 showsthatthetwo groupswere
very similar for the characteristics for which they were
matched.
lable 1. Characteristics ofCentral Processing Department (CPD)
and Nutrition Services (NS) groups.
Characteristic All CPD All NS
Smoking
Current (%) 18 (38) 18 (38)
Quitter (%) 10 (21) 7 (15)
Never(%) 19 (40) 22 (47)
No. cigarettes/day,a mean (SD) 17.2 (7.7) 17.7 (6.9)
Lifetime pack-years,b mean (SD) 16.4 (13.9) 16.8 (12.2)
Age, years, mean (SD) 42.1 (12.8) 43.0 (13.9)
Male(%) 4 (9) 4 (9)
Female (%) 43 (91) 43 (91)
aAmong current smokers.
bAmong current and past smokers.
Genetic Tests
EO has been shown to cause genetic damage in vito in
several studies ofworkers exposed to high levels. Astriking
increase in chromosomal aberrations (CA) was observed in
workers accidentally exposed 18 months previously to 1500
ppm EO for 2 hr (6). Several studies have shown that CA
are increased after exposure to high EO levels (7,8) but
sensitivity ofCA to low levels is less certain (8-10).
Statistically significant increases in sister chromatid
exchange(SCE)havealsobeenreportedafterexposureto
moderately high levels ofEO (8,11-14). The situation with
low-level exposure is less clear, with certain studies
demonstrating increased SCE at TWA exposures of less
than 0.5 ppm (8,15), but others not at TWA exposures of
less than 5 ppm (16-18). Several investigators have found
the elevation in SCE was persistent after high-level expo-
sure to EO (8,11,13).
Recent analysis ofSCE frequencies in monkeys chron-
ically exposed to EO has shown that persistent, elevated
SCE may be due to a subpopulation oflong-lived lympho-
cyteswithunusuallyhighSCE counts (19). Theanalysis of
these high-frequency cells (HFC) has become an impor-
tantadjuncttothestudyofSCE (20,21),particularlyinthe
case ofEO exposure in man (15,22). As SCEs have proven
to be sensitive to fairly low EO levels, persistent after
higher exposures, relatively easyto score, and to have low
interobserver variability, SCE analysis was chosen for
investigation ofgenotoxicity in the entire cohort.
Itwasdecidedtoinclude atestforgenemutation aswell
asSCE, asEOisknowntobeaDNAalkylatingagent.The
somatic cell mutation test (SCMT), developed byAlbertini
and collaborators (23), was chosen for investigation of
genotoxicity in the current CPD group and the past CPD
groupwiththelongestregularEOexposure.Twomethods
for detecting hypoxanthine phosphoribosyl transferase
(hprt) mutants have been developed: an autoradiographic
assay that detects 6-thioguanine (TG)-resistant variants
and a clonal assay that allows for the expansion of hprt
mutant clones, which can then be used to characterize the
molecularalterationinthegene.Thirty-nineCPDworkers
and their matched control subjects were included in an
autoradiographic SCMTanalysis. The10subjectswiththe
highest variant frequency (VF) and their matches were
further investigated with the clonal assay to characterize
the hprt mutation at the molecular level. The work on
cloned mutants is still in progress.
The method for SCE involved setting up two 10-mL
cultures per subject with 6 x 106 mononuclear cells
(MNC)fromdensitygradientcentrifugation (Histopaque;
Sigma, St. Louis, MO) in RPMI 1640 medium with 10%
fetalbovine serum (FBS; Gibco,Burlington, ON), 2%phyto-
hemagglutinin (PHA; Burroughs-Wellcome, Guelph, ON)
and onedropfrom aPasteurpipette ofthepacked redblood
cells. Cultureswere incubatedin a37°C incubatorwith 5%
CO2 for 68 hr with 20 [Lg/mL 5-bromodeoxyuridine
(BrdUrd) added for the final 44 hr before harvesting.
Slides were stained by Hoecsht 33258/fluorescence plus
Giemsa (24). Twenty-five cells were scored from both
cultures, giving a total of50 cells per individual.
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The method for the autoradiographic SCMT involved
cryopreservation ofMNCs for 3 days before initiation of2
mL cultures with 2 x 106 viable MNCs in RPMI 1640
medium with 10% FBS and 2% PHA, eitherwith (test) or
without (control) 2 x 10-4 M TG. Cells were incubated at
37°C and 5% CO2 for 30 hr before addition of tritiated
thymidine. Cultures were harvested 18 hr later and slides
prepared and stained forautoradiography (25,26). Labeled
nuclei were enumerated in control and test cultures and
VF was calculated by dividing the total number oflabeled
nuclei in the test cultures by the number in the control
cultures (27).
Study Design
Samples were collected from both members of a
matched pair on the same day, after obtaining informed
consent and completing a questionnaire. Information on
EO exposure and on potential confounding factors, includ-
ing illnesses, treatments, and other relevant hazardous
exposures, was collected by interviews using question-
naires.
For SCE and SCMT analyses, 60 mL of venous blood
was collected into vacuum blood containers (Venoject;
sodium heparin). Care was taken to ensure that all nee-
dles, containers, and tissue culture plastieware were not
contaminated with EO. Mononuclear cells were separated
bygradientcentrifugation tobeusedimmediatelyforSCE
cultures or to be cryopreserved for the SCMT.
Estimation of Exposure and Statistical
Analyses
For this analysis, the exposure variable was based on
the number of months of "regular work" (MOREG) that
individualsworked inthe CPD area. Forexample, a super-
visor who does not work fulltime in the sterilizing facility
would accumulate months ofregular exposure at a propor-
tionately lower rate than a sterilizer operator. Thus, this
exposure variable combines both a component ofdose and
one of duration.
The SCE data were analyzed in several ways. In addi-
tion to considering the mean frequency of SCE for all 50
cells of a subject (all 50), it was also possible to study a
subset of cells with a high frequency of SCE (HFC). The
mean SCE frequency for each subject's top 10 and top 5
cells (top 10 and top 5, respectively) were calculated.
Whereas the data for all 50 cells closely approximated a
normal distribution, the data for top 10 and top 5 were log
transformed before analysis to make the distributions
conform to normality assumption requirements. These
continuous variables were then analyzed by linear regres-
sionanalysis (BMDP Statistical Software, Inc., University
ofCalifornia Press, Berkeley, CA, 1990) using MOREG as
the exposure variable; number of cigarettes currently
smoked (CIGNOW), age and sex as covariates; and all
exposure-related interactions in the model.
Another approach was to consider the SCE frequency
distribution ofthenonsmokingNUTR controls andtotake
the 95th percentile of that distribution to be the cut-off,
above which a cell would be defined as an HFC. Binomial
distribution theory wasusedto determinetheexpected (or
normal) number of HFC for an individual (28). If an
individual had >5 HFC cells, that individual was consid-
erded "abnormal." The HFC count data were therefore
categorical and were analyzed by a logistic regression
analysis. In addition to the logistic regression analysis of
this data, the chi-square test was used to compare groups
(22).
Results
Linear regression analysis of the mean SCE for all 50
cells and thelog-transformed mean SCE forthe top5 cells
for the 94 CPD and NUTR workers indicated that there
was a significant association with CIGNOW but not with
EO exposure history(MOREG). Logisiticregression dem-
onstrated the same relationships for the proportion of
individuals who were classified as having an abnormally
highnumberofHFC.Table2 showstheresultsforall CPD
workers and their NUTR matches; Table 3 shows the
results for smokers, individualswho had stopped smoking,
and thosewho had never smoked. Asignificant association
with sex wasfoundforall50, top10, andtop5,withfemales
having higher SCE frequencies (p = 0.04, 0.03, 0.03,
respectively). There were no males classified as having an
abnormal number ofHFC, so the logistic regression anal-
ysis ofthe HFC countdata gave ameaninglessF-ratio and
p-value for sex. The result ofthe chi-square test on HFC
count showed borderline significance (X2 = 3.71, p =
0.05).
Linear regression analysis ofthe log-transformed vari-
ant frequency found no signficant association with either
CIGNOW or MOREG. Aweak association ofVF with age
was observed (p = 0.06). The linear regression for VF
included the labeling index of the control cultures as an
independentvariable, butit did not significantly affectVF.
Table 4 summarizes the SCE and SCMT data for hospi-
tal workers who worked in the CPD area or Nutrition
Services either currently or in the past. Regression analy-
ses for the 72 past employees only gave similar results to
the analysis based on all 94 workers, except that signifi-
Table 2. Descriptive statistics for SCE and SCMT
variables by exposure group.
All CPD All NS
(SCE, n = 47; (SCE, n = 47;
Variablea SCMT, n = 39) SCMT, n = 39)
SCE
All 50, mean (SD) 14.5 (2.1) 14.6 (1.6)
Top 10, geometric mean 20.6 20.6
Top 5, geometric mean 22.4 22.4
% HFC, median1' 6.0 (8.0) 6.0 (8.0)
HFC count, (%) 14 (30) 14 (30)
SCMT
VF x 10-6, geometric mean 7.4 7.8
Abbreviations: SCE, sister chromatid exchange; SCMT, somatic cell
mutation test; CPD, Central Processing Department; NS, Nutrition
Services; HFC, cellswith high frequency ofSCE; VF,variant frequency.
aSee text for details.
hInterquartile range in parentheses.
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Tble 3. Descriptive statistics for SCE and SCMT variables by smoking group.
Current smoker Quit smoking Never smoked
(SCE, n = 36; (SCE, n = 17; (SCE, n = 41;
Variablea SCMT, n = 34) SCMT, n = 11) SCMT, n = 33)
SCE
All 50, mean (SD) 15.6 (1.8) 14.1 (1.2) 13.8 (1.7)
Top 10, geometric mean 22.1 20.0 19.6
Top 5, geometric mean 24.0 21.8 21.2
% HCF, medianb 12.0 (11.5) 4.0 (5.0) 4.0 (6.0)
HFC count, (%) 19 (53) 2 (12) 7 (17)
SCMT
VF x 10-6, geometric mean 8.2 6.8 7.3
Abbreviations: SCE, sister chromatid exchange; SCMT, somatic cell mutation test; HFC, cells with high frequency ofSCE; VF, variant frequency.
aSee text for details.
bInterquartile range in parentheses.
Table 4. Descriptive statistics for SCE and SCMT variables by past or current exposure groups.
Current CPD Past CPD Current NS Past NS
(SCE, n = 11; (SCE, n = 36; (SCE, n = 11; (SCE, n = 36;
Variablea SCMT, n = 11) SCMT, n = 28) SCMT, n = 11) SCMT, n = 28)
SCE
All 50, mean (SD) 15.3 (1.7) 14.3 (2.1) 14.7 (1.4) 14.5 (1.7)
Top 10, geometric mean 21.6 20.3 21.0 20.5
Top 5, geometric mean 23.3 22.1 22.9 22.2
% HFC, medianb 8.0 (12.0) 5.0 (9.5) 8.0 (8.0) 5.0 (10.0)
HFC count(%) 5 (45) 9 (25) 4 (36) 10 (28)
SCMT
VF x 10-6, geometric mean 10.4 6.5 20.4 5.4
Abbreviations: SCE, sister chromatid exchange; SCMT, somatic cell mutation test; CPD, Central Processing Department; NS, Nutrition Services;
HFC, cells with high frequency ofSCE; VF, variant frequency.
aSee text for details.
bInterquartile range in parentheses.
cant interactions between smoking and occupation were DNAsynthesis. However, the results ofstudieswhere the
observed for the top 5 and top 10 cells (p = 0.01 and 0.02, exposures were less than 1 ppm have been inconsistent.
respectively). No other interactions in any other analyses Recently, a study of 34 hospital workers exposed to less
werefoundtobestatisticallyorclinicallysignificant.Thus, than 1 ppm (TWA) and 23 controlsworkingin auniversity
themaineffectsreported above aretakenfromregression library found a significant effect ofexposure on SCE and
analyses that excluded interaction terms (Table 5). EO-hemoglobin adducts, but not with micronuclei, chro-
mosomal aberratons, single-strand DNA breaks, or an
index of DNA repair (15). However, the effect of EO
Discussion exposure on SCE was statistically significant only in an
analysis of variance where smokers and quitters were
Studies in the past have demonstrated that EO expo- combined, even though quitters were not found to be
sures of TWA greater than 5 ppm result in increased statistically different from lifetime nonsmokers. When
chromosome aberrations, sister chromatid exchange, and quitters and nonsmokers were combined, no statistically
other genotoxic effects such as damaged unscieduled significant effect ofEO exposure was shown.
Table 5. Statistical significance on regression analyses.
Dependent Group F-ratio, p-value
variablea (df) MOREG Age CIGNOW Sex
All 50 All (89) NS NS 21.6,<0.0001 4.46,0.038
Past (67) NS NS 20.0,<0.0001 3.69,0.059
Top 5 (Ln) All (89) NS NS 28.5,<0.0001 4.60,0.035
Past (67) NS NS 19.7,<0.0001 3.65,0.060
HFC count All (89) NS NS 15.9,0.0001 b
Past(67) NS NS 8.2,0.0056 b
VF (ln) All (73) NS 3.53,0.064 NS NS
Past (51) NS 3.78,0.057 NS NS
Abbreviations: df, degrees offreedom; MOREG, months ofregularwork; CIGNOW, cigarettes currently smoked; HFC, cells with high frequency of
SCE; VF, variant frequency.
aSee text for details.
bAs there were no males with abnormal numbers ofHFC, the F-ratio and p-value for sex as an independent variable were meaningless.
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The results ofthe present study, and aprevious one in a
steel foundry (29), indicate that lifetime nonsmokers and
quitters have similar SCE frequencies, significantly lower
than smokers. Therefore, an analysis ofvariance combin-
ing quitters with smokers would not be justifiable. The
presentregression analyseswith CIGNOWas acovariate
combined nonsmokers and quitters in the sense thatboth
groupscurrentlysmokedzerocigarettesperday.Stepwise
regression ofsmokingvariables in ourdatahad shownthe
major contribution to SCE variance to arise from current
smoking, with no additional effect of previous smoking
history.
No significant association of elevated SCE or SCMT
with EO exposure historywas demonstrated in this group
ofhospitalworkers. Interaction between smoking and EO
exposurewasobserved onlywhenthe11currentlyexposed
workers and their matches were excluded from the anal-
ysis. Given that there was no evidence of an interaction
when all workers were included in the analyses, even
though the current workers also had past exposures, it is
hard to conclude that this is a biologically important
interaction. No interactions were observed forthe genetic
variables in the study ofMayer and co-workers (15).
The SCMT test has recently been evaluated in two
occupational groups exposured to EO: hospital workers
with an8-hrTWAofabout 1 ppmandfactoryworkerswith
an8-hrTWAofabout15ppm(22).Asignificantassociation
of mutant frequency with exposure was found in the
factory workers, but not in the hospital workers. This
indicates that the SCMT is less sensitive than SCE, as a
small but statistically significant increase in SCE was
observed in the hospital workers in the same study.
In the present study, therewas no detectable change in
SCMTinhospitalworkerscurrentlyexposed tolessthan1
ppm(TWA) orexposedtohigherlevelsinthepast.Prelimi-
nary work from the study reported above indicates that
thatthere maybe ahot spotforabase substitution in exon
9ofthehprt gene (Van Zeeland,personal communication).
Therefore it may be possible to detect a change in muta-
tional spectrum in cryopreserved mutant T-cell clones
from the EO-exposed hospital workers.
No association between EO exposure history and
genetic indicators were found in the present study. These
findings are consistent with some, but not all, results of
recent studies oflow-level EO exposure (15-18). However,
the number ofcurrentlyexposedworkers in theproject (n
= 11)istoosmall toexcludewithconfidencethepossibility
of a link between current exposure levels and genotox-
icologic effects.
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